Insugen-R 100IU/ml Solution for Injection contains human insulin at a concentration of 100 IU per milliliter and is indicated for the management of diabetes mellitus requiring insulin therapy. This rapid-acting insulin analog facilitates the regulation of blood glucose levels by promoting cellular glucose uptake and inhibiting hepatic glucose production. Insugen-R is typically administered subcutaneously before meals to control postprandial hyperglycemia, with dosing individualized based on patient’s glycemic control, lifestyle, and dietary intake. The solution is clear and colorless, suitable for use with insulin syringes or insulin pumps. It is essential to monitor blood glucose regularly to adjust the insulin dose appropriately and minimize the risk of hypoglycemia. Insugen-R should be used cautiously in patients with renal or hepatic impairment, and dose adjustments may be necessary. Common adverse effects include hypoglycemia, injection site reactions, and lipodystrophy with repeated administration at the same site. Patients should be educated on recognizing and managing hypoglycemia and the importance of adherence to prescribed dosing schedules. Insugen-R is contraindicated in patients with hypersensitivity to human insulin or any excipients in the formulation. Proper storage and handling instructions must be followed to maintain insulin potency and efficacy.